marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-14-2024
Seelos Therapeutics Financial Ratios 2011-2024 | SEEL
Annual Financial Ratios Seelos Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.1 | -0.1 | -1.4 | -5.3 | -0.4 | -0.4 | 89.7 | -2.1 | -2.9 | -2.5 | -4.7 | -2.3 | -5.5 |
P/S |
2.5 | - | - | - | 57.9 | - | - | 2.7 | 11.4 | 5.9 | 31.4 | 8.7 | 24.3 |
EPS |
-7.7 | -20.7 | -0.7 | -0.4 | -2.5 | -1.1 | 0.8 | -1.1 | -3.8 | -0.6 | -0.5 | -1.2 | -0.9 |
EV (Enterprise Value) |
41.4 M | 21.8 M | 38.3 M | 101 M | 22.6 M | 4.5 M | 24.8 M | 25.4 M | 69.1 M | 56.5 M | 69.7 M | 75.2 M | 104 M |
EBITDA per Share |
-8.26 | -20 | -0.679 | -0.398 | -1.44 | -12 | -26.6 | -60.3 | -126 | -183 | -163 | -94.4 | -263 |
EV/EBITDA |
-0.6 | -5.1 | -0.4 | 0.0 | -2.1 | -1.5 | -2.9 | -2.0 | -3.2 | -7.1 | -5.5 | ||
PEG |
-0.0 | -0.0 | 0.03 | -0.08 | -0.01 | 0.0 | 0.88 | -0.03 | -0.09 | 0.21 | -0.08 | 0.08 | -0.09 |
P/B |
-0.2 | -0.4 | 1.6 | 39.5 | -3104.3 | 1.3 | 6.6 | -2.0 | -5.6 | 28.7 | 7.2 | 11.0 | 20.7 |
P/CF |
-0.2 | -0.1 | - | -4.9 | -1.1 | -0.4 | -2.7 | -1.2 | -2.4 | -3.0 | -5.0 | -4.9 | -10.0 |
ROE % |
113.05 | 693.00 | -115.22 | -742.65 | 726857.14 | -359.33 | 7.34 | 98.90 | 191.30 | -1135.28 | -154.37 | -479.85 | -376.02 |
ROA % |
-699.19 | -323.28 | -79.10 | -109.19 | -458.54 | -245.80 | 4.79 | -158.15 | -242.18 | -147.11 | -72.66 | -133.05 | -109.04 |
ROCE % |
120.86 | 668.33 | -107.58 | -186.38 | -9236.48 | -353.48 | -208.33 | 203.11 | 268.86 | -308.30 | -162.74 | -128.80 | -275.66 |
Current Ratio |
0.1 | 0.7 | 3.2 | 2.4 | 1.0 | 3.1 | 4.2 | 0.3 | 0.4 | 1.9 | 1.9 | 1.9 | 0.8 |
DSO |
- | - | - | - | - | - | - | 33.6 | 39.1 | 26.7 | 8.6 | 29.4 | 29.1 |
DIO |
- | - | - | - | - | - | - | 71.7 | 185.7 | 109.3 | 46.6 | - | 22.2 |
DPO |
- | - | - | - | - | - | - | 90.1 | 625.5 | 341.9 | 128.5 | 183.1 | 185.6 |
Operating Cycle |
- | - | - | - | - | - | - | 105.2 | 224.8 | 136.1 | 55.2 | 29.4 | 51.3 |
Cash Conversion Cycle |
- | - | - | - | - | - | - | 15.2 | -400.7 | -205.9 | -73.3 | -153.7 | -134.3 |
All numbers in USD currency
Quarterly Financial Ratios Seelos Therapeutics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.68 | -0.2 | - | 0.08 | -53.66 | -3.58 | - | -0.18 | -0.2 | -0.13 | - | -0.11 | -0.1 | -0.28 | - | -0.09 | -0.08 | -0.14 | - | -0.13 | -0.09 | -3.98 | - | -0.036 | -0.16 | -0.21 | - | -0.29 | -0.13 | 1.04 | - | -0.19 | -0.54 | -0.46 | -0.05 | -1 | -0.1 | -0.13 | -0.4 | -0.08 | 0.05 | -0.09 | -0.04 | -0.08 | -0.4 | -0.29 | -0.66 | -0.12 | -0.19 | -0.2 | -0.22 | -0.11 | -0.39 | -0.18 |
EBITDA per Share |
- | - | - | - | - | - | - | -0.16 | -0.2 | -0.13 | - | -0.11 | -0.08 | -0.24 | - | -0.09 | -0.08 | -0.16 | - | -0.15 | -0.16 | -1.38 | - | -0.35 | -0.14 | -0.2 | - | -0.27 | -0.21 | -0.23 | - | -0.23 | -0.72 | -0.86 | - | -1.12 | -0.11 | -0.13 | - | -0.08 | 0.03 | -0.09 | - | -0.08 | -0.12 | -0.2 | - | -0.06 | -0.16 | -0.15 | - | -0.09 | -0.37 | -0.15 |
ROE % |
-67.07 | 1.53 | 93.01 | -155.80 | -370.09 | -513.72 | -360.60 | -375.43 | -141.45 | -71.06 | -102.75 | -261.77 | -405.96 | -540.23 | -491.87 | 45522.41 | 91695.72 | 118454.99 | 579942.86 | 579966.17 | 533975.19 | 507371.47 | 47.92 | -39.75 | -150.73 | -195.01 | 63.30 | 80.48 | 185.33 | 263.46 | 94.92 | 118.37 | 151.82 | 160.15 | 191.30 | -733.04 | -945.88 | -900.81 | -1135.28 | -246.65 | -111.64 | -245.31 | -154.37 | -438.72 | -449.18 | -487.72 | -479.85 | -280.64 | -289.04 | -376.41 | -376.02 | -46.08 | -161.76 | -70.79 |
ROA % |
335.73 | 15.82 | -136.07 | -184.47 | -401.70 | -173.41 | -88.01 | -101.37 | -46.53 | -56.34 | -69.38 | -92.76 | -102.77 | -114.28 | -72.32 | -101.34 | -106.99 | -102.47 | -365.86 | -940.21 | -1485.52 | -1728.94 | -1180.63 | -1237.77 | -720.57 | -482.34 | 41.26 | 13.79 | 43.47 | -5.57 | -151.79 | -181.76 | -218.99 | -215.37 | -244.48 | -331.25 | -287.57 | -207.49 | -147.11 | -36.14 | -27.93 | -57.48 | -72.66 | -149.13 | -146.77 | -150.52 | -133.05 | -79.05 | -81.96 | -108.24 | -109.04 | -13.36 | -46.91 | -20.53 |
ROCE % |
112.33 | 124.39 | 107.89 | -113.07 | -375.48 | -479.68 | -332.65 | -347.61 | -141.61 | -68.82 | -90.25 | -249.07 | -392.93 | -513.83 | -502.10 | 52083.61 | 104828.15 | 153442.95 | 277385.71 | 277408.81 | 224846.20 | 176369.43 | 45.56 | -39.46 | -147.57 | -212.36 | -183.25 | -160.37 | -52.47 | 64.91 | 148.63 | 207.88 | 244.25 | 241.27 | 179.37 | 13.56 | -211.51 | -205.19 | -285.57 | -314.39 | -177.41 | -279.22 | -121.92 | -157.03 | -163.32 | -192.04 | -156.83 | -203.08 | -214.21 | -311.06 | -279.83 | -46.24 | -162.51 | -71.08 |
Current Ratio |
0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.5 | 0.7 | 1.2 | - | 2.8 | 3.2 | 10.1 | 11.9 | 2.5 | 1.2 | 1.2 | 1.2 | 1.2 | 1.0 | 1.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.9 | 2.9 | 2.9 | 2.9 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 1.1 | 1.1 | 1.1 | 1.1 | 1.9 | 1.9 | 1.7 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 |
DSO |
140.3 | 136.4 | - | 73.3 | 166.2 | 44.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 11.5 | 135.2 | 88.0 | 18.0 | 37.2 | 102.5 | 115.0 | 32.4 | 32.6 | 11.3 | - | 14.9 | 192.3 | 4.5 | 34.9 | 25.0 | 12.2 | 20242.3 | 47.7 | 132.3 | 37.3 | 18.7 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
140.3 | 136.4 | - | 73.3 | 166.2 | 44.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 11.5 | 135.2 | 88.0 | 18.0 | 37.2 | 102.5 | 115.0 | 32.4 | 32.6 | 11.3 | - | 14.9 | 192.3 | 4.5 | 34.9 | 25.0 | 12.2 | 20242.3 | 47.7 | 132.3 | 37.3 | 18.7 | - |
Cash Conversion Cycle |
140.3 | 136.4 | - | 73.3 | 166.2 | 44.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 11.5 | 135.2 | 88.0 | 18.0 | 37.2 | 102.5 | 115.0 | 32.4 | 32.6 | 11.3 | - | 14.9 | 192.3 | 4.5 | 34.9 | 25.0 | 12.2 | 20242.3 | 47.7 | 132.3 | 37.3 | 18.7 | - |
All numbers in USD currency